Cardiovascular risk factors in young adult survivors of childhood acute lymphoblastic leukemia

被引:139
作者
Oeffinger, KC
Buchanan, GR
Eshelman, DA
Denke, MA
Andrews, TC
Germak, JA
Tomlinson, GE
Snell, LE
Foster, BM
机构
[1] Univ Texas, SW Med Ctr, Dept Family Practice & Community Med, After Canc Experience Young Adult Program, Dallas, TX 75390 USA
[2] Univ Texas, SW Med Ctr, Dept Pediat, Dallas, TX USA
[3] Univ Texas, SW Med Ctr, Ctr Canc & Blood Disorders, Dallas, TX USA
[4] Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX USA
[5] Univ Texas, SW Med Ctr Acad Comp Serv, Dallas, TX 75235 USA
[6] Childrens Med Ctr Dallas, After Canc Experience Program, Dallas, TX USA
[7] Ohio State Univ, Dept Pediat, Columbus, OH USA
关键词
acute lymphoblastic leukemia; survivors; longterm; cardiovascular disease; risk factors;
D O I
10.1097/00043426-200110000-00007
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To assess cardiovascular risk factors (CVRF) in young adult survivors of childhood acute lymphoblastic leukemia (ALL). Patients and Methods: Twenty-six subjects (median age, 20.9 years: median interval since completion of therapy, 13.3 years) were evaluated. Ten participants had received cranial irradiation (CRT), whereas 16 had received only chemotherapy. Primary outcome measures included body mass index (BMI), blood pressure, fasting lipoprotein, glucose, and insulin levels. Secondary measures included insulin-like growth factor-1 (IGF-1) and IGF binding protein-3 levels, physical activity index, a 7-day dietary recall, tobacco product use. and measurement of the intima-media thickness (IMT) of the common carotid artery. Results: Sixty-two percent (16/26) of participants had at least one CVRF potentially related to their cancer treatment (obesity, dyslipidemia, increased blood pressure, or insulin resistance), with 30% (7/26) having more than two CVRF. Thirty-one percent (8/26) of subjects were obese (BMI greater than or equal to 30). Subjects who were treated with CRT (BMI 30.4 +/- 6.7) had an increased BMI (P = 0.039) in comparison with those who received only chemotherapy (BMI, 25.4 +/- 5.1). Triglyceride and very low-density lipoprotein C levels were significantly higher in those treated with CRT (P = 0.027 and 0.022, respectively). The IGF-1 was inversely correlated with IMT (total group, -0.514, P = 0.009: females only, -0.729. P = 0.003). Conclusions: Young adult survivors of childhood ALL, especially those treated with CRT. are at risk for obesity and dyslipidemia. insulin resistance, hypertension, and cardiovascular disease. Further investigation of these risks is warranted.
引用
收藏
页码:424 / 430
页数:7
相关论文
共 60 条
[1]   Adult height after cranial irradiation with 24 Gy: Factors and markers of height loss [J].
Adan, L ;
Souberbielle, JC ;
Blanche, S ;
Leverger, G ;
Schaison, G ;
Brauner, R .
ACTA PAEDIATRICA, 1996, 85 (09) :1096-1101
[2]   Effects of four years' treatment with biosynthetic human growth hormone (GH) on glucose homeostasis, insulin secretion and lipid metabolism in GH-deficient adults [J].
Al-Shoumer, KAS ;
Gray, R ;
Anyaoku, V ;
Hughes, C ;
Beshyah, S ;
Richmond, W ;
Johnston, DG .
CLINICAL ENDOCRINOLOGY, 1998, 48 (06) :795-802
[3]  
[Anonymous], 1997, ARCH INTERN MED, V157, P2413, DOI [10.1001/archinte.1997.00440420033005, DOI 10.1001/ARCHINTE.1997.00440420033005]
[4]   Persistent elevation of plasma insulin levels is associated with increased cardiovascular risk in children and young adults - The Bogalusa Heart Study [J].
Bao, WH ;
Srinivasan, SR ;
Berenson, GS .
CIRCULATION, 1996, 93 (01) :54-59
[5]   The effect of hypopituitarism on life expectancy [J].
Bates, AS ;
VantHoff, W ;
Jones, PJ ;
Clayton, RN .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (03) :1169-1172
[6]   Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults [J].
Berenson, GS ;
Srinivasan, SR ;
Bao, WH ;
Newman, WP ;
Tracy, RE ;
Wattigney, WA .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (23) :1650-1656
[7]   THE EFFECTS OF SHORT AND LONG-TERM GROWTH-HORMONE REPLACEMENT THERAPY IN HYPOPITUITARY ADULTS ON LIPID-METABOLISM AND CARBOHYDRATE-TOLERANCE [J].
BESHYAH, SA ;
HENDERSON, A ;
NITHTHYANANTHAN, R ;
SKINNER, E ;
ANYAOKU, V ;
RICHMOND, W ;
SHARP, P ;
JOHNSTON, DG .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1995, 80 (02) :356-363
[8]   Growth hormone deficiency and cardiovascular risk [J].
Best, JD ;
O'Neal, D ;
Kamarudin, N ;
Alford, FP ;
Best, JD .
BAILLIERES CLINICAL ENDOCRINOLOGY AND METABOLISM, 1998, 12 (02) :199-216
[9]  
Birkebaek NH, 1998, MED PEDIATR ONCOL, V30, P351, DOI 10.1002/(SICI)1096-911X(199806)30:6<351::AID-MPO9>3.0.CO
[10]  
2-D